MainBoardListed
Supriya Lifescience Limited
Company websiteSupriya Lifescience Limited is going public with an issue of ₹2,55,47,445 crore. The fresh portion of ₹72,99,270 crore typically funds growth or debt reduction.
The OFS of ₹1,82,48,175 crore provides liquidity to selling shareholders. Apply between 16-12-2021 and 20-12-2021; allotment expected on 23-12-2021.
Start Date16-12-2021
End Date20-12-2021
Listing Date28-12-2021
Allotment Date23-12-2021
Current Price₹421
GMP₹130 (47.45%)
Lot Size54 Shares
Subscription0 Times
Face Value₹2 Per Share
Listing atNSE, BSE
Issue Price₹265 - ₹274
Pre Issue₹7,31,83,530
Post Issue₹2,55,47,445
Issue Size₹2,55,47,445
(aggregating up to 700.00 Cr)
(aggregating up to 700.00 Cr)
Fresh Issue₹72,99,270
(aggregating up to 200.00 Cr)
(aggregating up to 200.00 Cr)
Offer For Sale₹1,82,48,175
(aggregating up to 500.00 Cr)
(aggregating up to 500.00 Cr)
The Grey Market Premium (GMP) for Supriya Lifescience Limited is currently around ₹130 (47.45%). This indicates an estimated listing price of approximately ₹395 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
09 Apr 2025, 10:29 | ₹274 | ₹130 | ₹404 (47.45%) |
Financials overview in Lakhs
Here is a quick look at the recent financial performance of Supriya Lifescience Limited . The numbers below ( in Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
The IPO reservation for Supriya Lifescience Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
QIB | 75.00% | 1,91,60,585 |
NII (HNI) | 15.00% | 38,32,116 |
RETAIL | 10.00% | 25,54,744 |
TOTAL | 100.00% | 2,55,47,445 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 54 | ₹14,796 | |
sHNI | 14 | 756 | ₹2,07,144 | |
bHNI | 68 | 3,672 | ₹10,06,128 |
Below you can find the official contact details of Supriya Lifescience Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: Supriya Lifescience Limited
Phone: +91-22-40332727
Website: https://supriyalifescience.com/
Address: 207/208, Udyog Bhavan, Sonawala Road, Goregaon, East, Mumbai – 400063, Maharashtra, India
IPO Registrar
Name: Link Intime India Private Limited
Phone: +91-22-4918 6270